treatment for patients with skin cancer / cancer treatment / cancer therapy / /
MedicalCondition
cancer / suitable solid tumours / skin cancer / infectious agents / tumour / Herpes / metastatic melanoma / /
MedicalTreatment
surgery / cancer therapy / /
Organization
office of the Gene Technology Regulator / office of the Gene Technology Regulator MDP / office of the Gene Technology Regulator Website Dr Michael Dornbusch Acting Gene Technology Regulator / Therapeutic Goods Administration / / /
NOTIFICATION OF APPLICATION Receipt of licence application (DIR 132) from Amgen Australia Pty Ltd for the commercial release of a tumour-selective genetically modified organism for cancer therapy Application The Office o